Collectively, these results suggest an increase in phosphatidylserine exposure early in AD, possibly regulated by synaptic tau aggregation through interaction with flippases regulating the membrane localisation of phosphatidylserine [64] or by directly interacting with phosphatidylserine [44]. The gene discussed is MAPT; the disease is Alzheimer disease.